Uncertainty in Govorestat Approval Dampens Market Sentiment

Applied Therapeutics shares are trading lower after the company announced they are awaiting FDA meeting minutes to determine the path for govorestat's regulatory submission, leading to uncertainty regarding its approval timeline.